Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal stem cells for digital ulcers in systemic sclerosis
2015-000168-32Phase 2Active
- Sponsor
- University Medical Center Utrecht
- Start
- Jul 2015
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, single-arm trial of human mesenchymal stem cells in systemic sclerosis (SSc), sponsored by University Medical Center Utrecht. Primary endpoint: Serious adverse events. Started Jul 2015; status: active.
02
Drugs
human mesenchymal stem cells
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on 2015-000168-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000168-32.